Literature DB >> 30719120

Inflammatory biomarkers in prognostic analysis for patients with glioma and the establishment of a nomogram.

Tong Yang1, Ping Mao1, Xianhai Chen1, Xuan Niu1, Gaofeng Xu1, Xiaobin Bai1, Wanfu Xie1.   

Abstract

Being biomarkers that reflect host nutritional and immune status, prognostic nutritional index (PNI) and neutrophil/lymphocyte ratio (NLR) have been identified to be independent prognostic factors in various malignancies. The aim of the present study was to determine the predictive value of these parameters for the prognosis of patients with glioma. Hematological and clinicopathological data were retrospectively analyzed from 128 patients with glioma who underwent brain tumor resection between January 2008 and December 2012. Receiver operating characteristic (ROC) analysis was used to determine the optimal cut-offs for PNI and NLR. Kaplan-Meier survival analysis, and univariate and multivariate analyses based on Cox proportional hazards regression model were used to determine whether NLR and PNI were associated with the prognosis of patients with glioma. R software was used to develop nomograms with all the independent prognostic factors included. Kaplan-Meier analysis followed by log-rank tests indicated that NLR ≥2.8 and PNI <45 were significantly associated with decreased overall survival time. The subsequent multivariate analysis indicated that age ≥50 years [hazard ratio (HR), 2.328; 95% confidence interval (CI), 1.386-3.908; P<0.001], high-grade glioma (HR, 3.088; 95% CI, 1.893-5.037; P<0.001), gross total resection (HR, 0.606; 95% CI, 0.380-0.965; P=0.035) and NLR ≥2.8 (HR, 2.037; 95% CI, 1.264-3.281; P=0.003) were independent prognostic factors. The results of the present study indicated that high NLR was an independent risk factor for overall survival rates in patients with glioma, which indicated its value in improving the current prognostic model.

Entities:  

Keywords:  glioma; neutrophil/lymphocyte ratio; prognosis; systemic inflammation

Year:  2018        PMID: 30719120      PMCID: PMC6351731          DOI: 10.3892/ol.2018.9870

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  27 in total

Review 1.  Immunity, inflammation, and cancer.

Authors:  Sergei I Grivennikov; Florian R Greten; Michael Karin
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

2.  Neutrophils responsive to endogenous IFN-beta regulate tumor angiogenesis and growth in a mouse tumor model.

Authors:  Jadwiga Jablonska; Sara Leschner; Kathrin Westphal; Stefan Lienenklaus; Siegfried Weiss
Journal:  J Clin Invest       Date:  2010-03-08       Impact factor: 14.808

Review 3.  Prognostic role of platelet to lymphocyte ratio in solid tumors: a systematic review and meta-analysis.

Authors:  Arnoud J Templeton; Olga Ace; Mairéad G McNamara; Mustafa Al-Mubarak; Francisco E Vera-Badillo; Thomas Hermanns; Boštjan Seruga; Alberto Ocaña; Ian F Tannock; Eitan Amir
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-05-03       Impact factor: 4.254

Review 4.  The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer.

Authors:  Graeme J K Guthrie; Kellie A Charles; Campbell S D Roxburgh; Paul G Horgan; Donald C McMillan; Stephen J Clarke
Journal:  Crit Rev Oncol Hematol       Date:  2013-04-17       Impact factor: 6.312

5.  Relation of cord serum levels of growth hormone, insulin-like growth factors, insulin-like growth factor binding proteins, leptin, and interleukin-6 with birth weight, birth length, and head circumference in term and preterm neonates.

Authors:  Hui-Chen Lo; Lon-Yen Tsao; Wen-Yin Hsu; Hsia-Nan Chen; Wai-Kit Yu; Chiu-Yen Chi
Journal:  Nutrition       Date:  2002 Jul-Aug       Impact factor: 4.008

Review 6.  Cancer-related inflammation.

Authors:  Alberto Mantovani; Paola Allavena; Antonio Sica; Frances Balkwill
Journal:  Nature       Date:  2008-07-24       Impact factor: 49.962

7.  Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer.

Authors:  Carsten Denkert; Sibylle Loibl; Aurelia Noske; Marc Roller; Berit Maria Müller; Martina Komor; Jan Budczies; Silvia Darb-Esfahani; Ralf Kronenwett; Claus Hanusch; Christian von Törne; Wilko Weichert; Knut Engels; Christine Solbach; Iris Schrader; Manfred Dietel; Gunter von Minckwitz
Journal:  J Clin Oncol       Date:  2009-11-16       Impact factor: 44.544

8.  Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3.

Authors:  Thierry Gorlia; Martin J van den Bent; Monika E Hegi; René O Mirimanoff; Michael Weller; J Gregory Cairncross; Elizabeth Eisenhauer; Karl Belanger; Alba A Brandes; Anouk Allgeier; Denis Lacombe; Roger Stupp
Journal:  Lancet Oncol       Date:  2007-12-21       Impact factor: 41.316

9.  The association of pre-treatment neutrophil to lymphocyte ratio with overall survival in patients with glioblastoma multiforme.

Authors:  R M Bambury; M Y Teo; D G Power; A Yusuf; S Murray; J E Battley; C Drake; P O'Dea; N Bermingham; C Keohane; S A Grossman; E J Moylan; S O'Reilly
Journal:  J Neurooncol       Date:  2013-06-19       Impact factor: 4.130

Review 10.  The 2007 WHO classification of tumours of the central nervous system.

Authors:  David N Louis; Hiroko Ohgaki; Otmar D Wiestler; Webster K Cavenee; Peter C Burger; Anne Jouvet; Bernd W Scheithauer; Paul Kleihues
Journal:  Acta Neuropathol       Date:  2007-07-06       Impact factor: 17.088

View more
  13 in total

Review 1.  Impact of nutraceuticals and dietary supplements on mitochondria modifications in healthy aging: a systematic review of randomized controlled trials.

Authors:  Lorenzo Lippi; Francesca Uberti; Arianna Folli; Alessio Turco; Claudio Curci; Francesco d'Abrosca; Alessandro de Sire; Marco Invernizzi
Journal:  Aging Clin Exp Res       Date:  2022-08-03       Impact factor: 4.481

2.  An independently validated survival nomogram for lower-grade glioma.

Authors:  Haley Gittleman; Andrew E Sloan; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2020-05-15       Impact factor: 12.300

3.  Pre-operative serum inflammation-based scores in patients with pituitary adenomas.

Authors:  Pedro Marques; Friso de Vries; Olaf M Dekkers; Wouter R van Furth; Márta Korbonits; Nienke R Biermasz; Alberto M Pereira
Journal:  Pituitary       Date:  2020-11-24       Impact factor: 4.107

4.  Glioma survival prediction from whole-brain MRI without tumor segmentation using deep attention network: a multicenter study.

Authors:  Zhi-Cheng Li; Jing Yan; Shenghai Zhang; Chaofeng Liang; Xiaofei Lv; Yan Zou; Huailing Zhang; Dong Liang; Zhenyu Zhang; Yinsheng Chen
Journal:  Eur Radiol       Date:  2022-03-12       Impact factor: 7.034

5.  A nomogram combining inflammatory markers and clinical factors predicts survival in patients with diffuse glioma.

Authors:  Ping Yan; Jian-Wen Li; Li-Gen Mo; Qian-Rong Huang
Journal:  Medicine (Baltimore)       Date:  2021-11-24       Impact factor: 1.817

6.  A comprehensive prognostic signature for glioblastoma patients based on transcriptomics and single cell sequencing.

Authors:  Fan Fan; Hao Zhang; Ziyu Dai; Yakun Zhang; Zhiwei Xia; Hui Cao; Kui Yang; Shui Hu; Yong Guo; Fengqin Ding; Quan Cheng; Nan Zhang
Journal:  Cell Oncol (Dordr)       Date:  2021-06-17       Impact factor: 6.730

7.  The Prognostic Role and Nomogram Establishment of a Novel Prognostic Score Combining with Fibrinogen and Albumin Levels in Patients with WHO Grade II/III Gliomas.

Authors:  Tianshu Jia; Rui Zhang; Fanfei Kong; Qianjiao Zhang; Zhuo Xi
Journal:  Int J Gen Med       Date:  2021-05-28

8.  Prognostic significance of preoperative serum albumin, albumin-to-globulin ratio, and prognostic nutritional index for patients with glioma: A meta-analysis.

Authors:  Mingchang Liu; Liwen Wang
Journal:  Medicine (Baltimore)       Date:  2020-07-02       Impact factor: 1.817

9.  Neutrophil-to-lymphocyte ratio, Factor VIII and Antithrombin III: inflammatory-clotting biomarkers in glioma.

Authors:  Tatiana Koudriavtseva; Veronica Villani; Svetlana Lorenzano; Diana Giannarelli; Enea Gino Di Domenico; Annunziata Stefanile; Marta Maschio; Giovanna D'Agosto; Fulvia Pimpinelli; Antonio Tanzilli; Edvina Galiè; Andrea Pace
Journal:  EXCLI J       Date:  2021-07-08       Impact factor: 4.068

Review 10.  Serum Inflammation-based Scores in Endocrine Tumors.

Authors:  Pedro Marques; Friso de Vries; Olaf M Dekkers; Márta Korbonits; Nienke R Biermasz; Alberto M Pereira
Journal:  J Clin Endocrinol Metab       Date:  2021-09-27       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.